Copy of 5 24

 

 Copy of 5 25

CAR T cell therapy in Singapore: Practical considerations for patients and families

Wednesday, 20 October 2021  |  17:00 - 18:00 ( UTC+8  | SGT )  

Check your Time Zone

 

Register Now homeimprovment.info   

 

SYNOPSIS


In patients with relapsed or difficult-to-treat acute lymphoblastic leukemia, CAR T cell therapy is increasingly being used. The results of CART in these patients have been truly remarkable; patients are now cured with manageable side effects.

In this talk, we will discuss the current landscape of CAR T cell therapy in Singapore. We will share what is available here, including an overview of early results, potential costs involved and an introduction to newer therapies on the horizon. We will address common concerns so that families know what to expect before and after treatment. We will also discuss common side effects and how to prevent them.

Join us for this talk as we journey from the bench to the bedside, to discuss how this breakthrough technology could potentially save the life of your loved ones. 

 

If you can't make it, you can still register to receive a copy of the webinar recording.

Medical professionals in Singapore may eligible for CME/CPE/CNE credits for attending this webinar.
 
Credits and Certificates of Attendance will only be issued for those who are able to attend the live session and are in adherence with VIVA's Attendance Policy.

 

 

SPEAKER 


Michelle Hermiston

Dr Bernice Oh

Consultant, Division of Paediatric Haematology and Oncology
Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute
National University Hospital

 

Dr Bernice Oh graduated with MBBS at the National University of Singapore and was trained in paediatrics in Singapore. 

Her clinical interests include the treatment of Childhood Leukaemias as well as Bone and Soft Tissue Sarcomas. She also has a keen interest in teaching and training the next generation of doctors and paediatricians. Her research interests are in: Immunotherapy for Childhood Leukaemias and Solid Tumours, and Treatment-related Toxicities of Childhood Cancers


TC Quah

CHAIR:

Assoc Prof Allen Yeoh

Head & Senior Consultant, Division of Paediatric Haematology and Oncology 
Khoo Teck Puat - National University Children's Medical Institute, National University Hospital
Head & Senior Consultant, Division of Paediatric Haematology and Oncology,
National University Cancer Institute, Singapore
Associate Professor, Department of Paediatrics,
Yong Loo Lin School of Medicine, National University of Singapore 

Viva-Goh Foundation Associate Professor​

 

Viva-Goh Foundation Associate Professor Allen Yeoh is a Senior Consultant and Associate Professor in Division f Paediatric Haematology and Oncology, Khoo Teck Puat-National University Children's Medical Institute, NUH and Yong Loo Lin School of Medicine, NUS. He trained in NUS and NUH and obtained his clinical and research fellowship in St Jude Children's Research Hospital.

A/Prof Allen Yeoh's interest is in childhood leukaemia. He is currently the principal investigator of the multi-centre Malaysia-Singapore ALL and AML trials competitively funded by NMRC and A*STAR/Singapore Cancer Syndicate. Currently these trials have been highly successful with > 80% and >60% projected cure. He is the first Singapore doctor to receive the American Society of Haematology Merit Award for his pioneering work in gene expression profiling in leukaemia. This work was one of the highest cited article in this field for 2003.

A/Prof Yeoh is also the recipient of numerous National and International Awards including Singapore Youth Award 2002, NUS Office of Life Sciences Award 2002, Asian Innovation Award (Gold) 2003, the NMRC-BMRC Clinician Scientist Award from 2005 to date, the NUHS-Mokhtar Riady Pinnacle Award 2013 (Translational Research Innovator Award) and the National Medical Excellence Awards 2014 (National Outstanding Clinician Scientist Award). 



Pre webinar video 11